Literature DB >> 1929289

Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis.

D W Denning1, D A Stevens.   

Abstract

Cilofungin, amphotericin B, and a combination of the two drugs were compared in a model of aspergillosis in immunocompetent mice in three experiments. Cilofungin was equivalent to amphotericin B in preventing death and eradicating cerebral aspergillosis, but it did not sterilize the kidneys. This is the first demonstration of the in vivo activity of cilofungin against any fungus other than Candida albicans. The mortality with combination therapy was higher than those with amphotericin B alone (P = 0.003) and cilofungin alone (P = 0.054), as was weight loss after infection, indicating antagonism between cilofungin and amphotericin B in this model. The mechanisms of action and antagonism remain to be explained.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929289      PMCID: PMC245166          DOI: 10.1128/AAC.35.7.1329

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

Authors:  D W Denning; D A Stevens
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

2.  Purification and properties of a new alpha-glucanase from Aspergillus oryzae.

Authors:  A K Kundu; S Manna
Journal:  Indian J Exp Biol       Date:  1971-01       Impact factor: 0.818

3.  LY121019 inhibits Neurospora crassa growth and (1-3)-beta-D-glucan synthase.

Authors:  C S Taft; C P Selitrennikoff
Journal:  J Antibiot (Tokyo)       Date:  1988-05       Impact factor: 2.649

4.  The extracellular system of beta-1,3-glucanases of Alternaria tenuissima and Aspergillus vesicolor.

Authors:  V Jirků; B Kraxnerová; V Krumphanzl
Journal:  Folia Microbiol (Praha)       Date:  1980       Impact factor: 2.099

5.  Location and biosynthetic regulation of endo-1,4-beta-glucanase in Aspergillus nidulans.

Authors:  K S Kwon; Y C Hah; S W Hong
Journal:  Microbios       Date:  1988

6.  Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.

Authors:  G S Hall; C Myles; K J Pratt; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

7.  Affinity chromatography of beta-glucosidase and endo-beta-glucanase from Aspergillus niger on concanavalin A-Sepharose: implications for cellulase component purification and immobilization.

Authors:  J Woodward; H J Marquess; C S Picker
Journal:  Prep Biochem       Date:  1986

8.  Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice.

Authors:  M H Kothary; T Chase; J D Macmillan
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

9.  The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis.

Authors:  A Schaffner; P G Frick
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  [Regulation of the biosynthesis of endo-1,4-beta-glucanase, eco-1,4-beta-glucosidase and cellobiase in Aspergillus terreus].

Authors:  O N Okunev; I D Svistova; N A Zherebtsov; E L Golovlev
Journal:  Mikrobiologiia       Date:  1983 Jan-Feb
View more
  26 in total

1.  Efficacy of micafungin alone or in combination against systemic murine aspergillosis.

Authors:  Javier Capilla Luque; Karl V Clemons; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 2.  Antifungal peptides: novel therapeutic compounds against emerging pathogens.

Authors:  A J De Lucca; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

3.  Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis.

Authors:  P E Verweij; K L Oakley; J Morrissey; G Morrissey; D W Denning
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Small Colony Variants of Pseudomonas aeruginosa Display Heterogeneity in Inhibiting Aspergillus fumigatus Biofilm.

Authors:  Rajesh Anand; Richard B Moss; Gabriele Sass; Niaz Banaei; Karl V Clemons; Marife Martinez; David A Stevens
Journal:  Mycopathologia       Date:  2017-08-07       Impact factor: 2.574

5.  Experimental evidence that granulocyte transfusions are efficacious in treatment of neutropenic hosts with pulmonary aspergillosis.

Authors:  Marife Martinez; Vicky Chen; Ann-Jay Tong; Kelsey Hamilton; Karl V Clemons; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

6.  Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.

Authors:  N Khardori; H Nguyen; L C Stephens; L Kalvakuntla; B Rosenbaum; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

7.  Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.

Authors:  V Petraitis; R Petraitiene; A H Groll; A Bell; D P Callender; T Sein; R L Schaufele; C L McMillian; J Bacher; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

8.  Are Cystic Fibrosis Aspergillus fumigatus Isolates Different? Intermicrobial Interactions with Pseudomonas.

Authors:  Hasan Nazik; Richard B Moss; Vyshnavi Karna; Karl V Clemons; Niaz Banaei; Kevin Cohen; Varun Choudhary; David A Stevens
Journal:  Mycopathologia       Date:  2016-11-07       Impact factor: 2.574

9.  Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.

Authors:  M B Kurtz; I B Heath; J Marrinan; S Dreikorn; J Onishi; C Douglas
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

Review 10.  Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.

Authors:  C A Lyman; T J Walsh
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.